GCP
LJPC

GSA Capital Partners’s La Jolla Pharmaceutical Company LJPC Stock Holding History

GSA Capital Partners’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,143
Closed -$104K – 1987
2021
Q3 		$104K Sell
26,143
-26,606
-50% -$106K 0.01% 1321
2021
Q2 		$226K Buy
+52,749
New +$226K 0.03% 1124
2020
Q1 		– Sell
-56,542
Closed -$222K – 1817
2019
Q4 		$222K Buy
+56,542
New +$334K 0.03% 1199
2019
Q3 		– Sell
-12,565
Closed -$116K – 1920
2019
Q2 		$116K Sell
12,565
-96,327
-88% -$726K 0.01% 1330
2019
Q1 		$700K Buy
108,892
+70,600
+184% +$460K 0.07% 493
2018
Q4 		$361K Buy
+38,292
New +$576K 0.04% 735
2018
Q3 		– Sell
-10,092
Closed -$294K – 2104
2018
Q2 		$294K Sell
10,092
-3,300
-25% -$102K 0.01% 1397
2018
Q1 		$399K Sell
13,392
-28,000
-68% -$903K 0.02% 1179
2017
Q4 		$1.33M Buy
41,392
+32,500
+365% +$1.06M 0.08% 427
2017
Q3 		$309K Buy
+8,892
New +$286K 0.02% 1225
2016
Q3 		– Sell
-44,900
Closed -$718K – 2170
2016
Q2 		$718K Buy
44,900
+22,400
+100% +$402K 0.04% 850
2016
Q1 		$470K Buy
+22,500
New +$401K 0.03% 1058

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GSA Capital Partners's LJPC Position: Q4 2021 in Review

GSA Capital Partners sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 26,143 shares — an estimated $104K sold.

GSA Capital Partners first reported a position in LJPC in Q1 2016 and held it in 12 quarters. The position peaked at $1.33M in Q4 2017. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • GSA Capital Partners reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 26,143 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $104K.
  • GSA Capital Partners first reported a position in La Jolla Pharmaceutical Company in Q1 2016 and held it in 12 quarters.
  • GSA Capital Partners's La Jolla Pharmaceutical Company position peaked at $1.33M in Q4 2017.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.